Edelweiss: Cancer Open Access (ISSN: 2689-6737)
Volume 1 Issue 1
Editorial
DOI Number: https://doi.org/10.33805/2689-6737.101
The Evolution in The Treatment of Multiple Myeloma Towards Targeted Magnetic Molecularly Imprinted Nanomedicines
Abstract
EditorialMultiple myeloma is the second more frequently haematological cancer in the western world, after non-Hodgkin lymphoma, being about the 1-2 % of all the cancers cases and the 10-13% of hematologic diseases. The disease is caused by an uncontrolled clonal proliferation View moreResearch Article
DOI Number: https://doi.org/10.33805/2689-6737.102
Examining Chemotherapy-Related Cognitive Changes in Colorectal Cancer Patients: A Feasibility Trial
Marie-Rose Dwek, Lorna Rixon, Alice Simon, Catherine Hurt and Stanton Newman
Abstract
IntroductionResearch suggests that chemotherapy may be related to a decline in cognitive functions such as memory and attention in some solid tumour cancer patient View moreResearch Article
DOI Number: https://doi.org/10.33805/2689-6737.103
The Utility of Visual Inspection with Acetic Acid in Cervical Cancer Screening
Abstract
IntroductionCervical cancer is the commonest malignant tumour of the female genital tract and one of the leading causes of cancer mortality in women worldwide with a global annual incidence of over 500,000 [1,2]. Greater than 85% of these new cases and about 88% of these cancer related deaths occur View moreResearch Article
DOI Number: https://doi.org/10.33805/2689-6737.104
Immunotherapy of Prostate Cancer Patients could Overexpress The Virulence Factor Genes of E.faecalis
Tayebe Talebzade, Fahimeh Baghbani arani, Soha Sadeghi, Arvin Haghighatfard, Niloofar Ahmadi, Massoud Houshmand and Ali Dezhgir
Abstract
IntroductionImmunotherapy is a new method for the treatment of some cancers and allergic diseases that by strengthening the immune system through some medications fights cancer cells. Rosenberg and his colleagues in the National Ins View moreReview Article
DOI Number: https://doi.org/10.33805/2689-6737.105
Screening for Prostate Cancer: To Screen or Not To Screen? A Review of The State-of-The-Art
Abstract
IntroductionProstate cancer is one of the most controversial issues of medical practice, preventive oncology and health care system. Some specialists argue for the necessity of screening, recommend all men aged 50 years and older to regularly undergo screening examination, and the initiative is welcomed by the public at l View moreResearch Article
DOI Number: https://doi.org/10.33805/2689-6737.106
Frozen Section Assessment of Bronchial Margins during Lung Carcinoma Surgeries: Report of the Experience at a Single Institution
Abstract
IntroductionMany thoracic surgeons consider frozen section analysis of bronchial margins during lobectomies “obligatory” to ensure complete local resection of the tumor in patients undergoing Non-Small Cell Lung Carcinoma (NSCLC) resection. However, “routine” frozen section analysis of the bronchial margin, wi View moreResearch Article
DOI Number: https://doi.org/10.33805/2689-6737.107
Routine Colonoscopy after Diverticulitis Should not be Performed to Rule Out Colorectal Cancer
Abstract
IntroductionThe prevalence of diverticular disease has increased over the past few decades, with estimates of up to 2/3 of the general Western population above 40 years of age currently being affected [1-5]. Possible explanations for the increase in prevalence are increased aging, dietary habits and an increase in average body mass index [6]. View moreResearch Article
DOI Number: https://doi.org/10.33805/2689-6737.108
Recurrence and Mortality Rates Among Receivers and Decliners of Conventional Adjuvant Breast Cancer Treatments
Abstract
Highlights9% of Receivers and 2% of Decliners experienced a DFS limiting event, while 3% of Receivers and 2% of Decliners died.After controlling for stage at diagnosis and type of oncology care received, no difference was found on the Adjusted Hazard ratio of DFS or mortality between Receivers View moreReview Article
DOI Number: https://doi.org/10.33805/2689-6737.109
Micronuclei (MN), an Important Cancer Biomarker
Abstract
IntroductionA biological marker is most useful for identification of various hazards and risk assessment. Many biological markers have been developed to estimate exposure and to assess the risk of adverse effects. In general, micronucleus analysis is utilized in both genotoxicity testing with its exposure which effects in View moreResearch Article
DOI Number: https://doi.org/10.33805/2689-6737.110